Scientific information has become easier to access, but interpreting it remains a considerable challenge. In a health-literacy survey conducted across 17 countries, over 40% of respondents reported difficulty judging the advantages and disadvantages of different treatment options, making it the most challenging of the twelve health-literacy tasks assessed. The difficulty is not simply understanding unfamiliar terminology or locating reliable information. Health literacy also involves evaluating the significance of scientific findings and determining how that information should influence decisions about health. This becomes particularly complicated when the science itself is still developing, because the same evidence can be interpreted as an exciting discovery, an unproven possibility, or a reason for skepticism.
Part of the challenge comes from the way scientific knowledge develops. An experiment may establish that a substance changes cellular behavior without fully explaining how the change occurs. Identifying a biological mechanism does not necessarily establish a therapeutic benefit, and even a positive clinical finding must be interpreted in relation to the population studied, the outcomes measured, and the magnitude of the observed effect. These distinctions can be lost when individual findings are presented without the experimental conditions that give them meaning. The resulting misunderstanding can operate in either direction: preliminary evidence may be treated as established medical knowledge, while genuine observations may be dismissed because they challenge existing expectations.
Molecular hydrogen (H₂) provides an unusually revealing example. Composed of just two hydrogen atoms, H₂ was long regarded as largely biologically inert in mammalian systems, an assumption supported by its chemical stability and relatively limited reactivity under ordinary physiological conditions. Yet in 2007, researchers reported that H₂ selectively reduced hydroxyl radicals in cultured cells and substantially reduced brain injury following experimentally induced ischemia and reperfusion in rats. The findings challenged the prevailing assumption that molecular hydrogen had little direct relevance to mammalian biology and established a foundation for investigating its potential biological effects.
The significance of that discovery extended beyond the protective effect observed in one experimental model. It raised a broader problem: how could a molecule with relatively limited chemical reactivity influence complex biological processes? The initial explanation centered on selective antioxidant activity, particularly the possibility that H₂ could reduce highly reactive species responsible for cellular damage without interfering with other reactive molecules involved in normal physiological signaling. This distinction mattered because reactive oxygen species (ROS) are not universally harmful. They also participate in processes such as cellular communication, metabolic regulation, and adaptation to physiological stress, making indiscriminate elimination of reactive species biologically undesirable.
However, the original antioxidant explanation did not resolve every question. In 2014, a chemical analysis challenged whether the reaction between H₂ and hydroxyl radicals was fast enough to explain substantial antioxidant effects under physiological conditions and found no detectable reaction between H₂ and peroxynitrous acid (ONOOH). These findings complicated the interpretation of the earlier biological observations without necessarily invalidating them. A substance can influence oxidative injury without functioning primarily as a direct scavenger of the reactive species associated with that injury. The difference becomes important when a proposed mechanism is treated as a complete explanation rather than one hypothesis that must continue to be tested.
Subsequent experiments began to identify other ways in which H₂ might influence redox-dependent biology. In 2016, researchers demonstrated that H₂ could modify the formation of oxidized phospholipid mediators generated during free-radical chain reactions, producing downstream changes in calcium signaling and gene expression. Rather than simply removing damaging molecules after they formed, H₂ appeared capable of influencing the chemical processes that generate signaling molecules and the cellular responses that follow. This provided a different framework for understanding how a relatively small chemical influence could produce broader biological effects.
More recently, the investigation has moved toward the mitochondrial machinery responsible for cellular energy production. In 2025, researchers reported that H₂ rapidly suppressed mitochondrial respiratory-chain Complex III activity and promoted degradation of the Rieske iron–sulfur protein through a process involving the mitochondrial protease LONP1. These changes were followed by activation of the mitochondrial unfolded protein response, an adaptive system that helps cells respond to disturbances in mitochondrial protein function. The findings introduced a potentially important mechanism in which an initial mitochondrial disturbance could activate subsequent protective or adaptive responses rather than simply preventing oxidative stress from occurring.
Even this explanation remains open to refinement. A 2026 commentary proposed that the Rieske protein might be an important mediator of H₂ signaling without necessarily being its initial molecular target, identifying other mitochondrial iron–sulfur proteins as candidates for further investigation. The distinction reflects how mechanistic research advances: identifying a pathway that contributes to an observed response is not always the same as identifying the first molecular interaction that initiates it. The evolving understanding of H₂ therefore does not represent a simple progression from an incorrect explanation to a correct one, but an expanding investigation into the different levels at which the molecule may influence cellular function.
The importance of distinguishing observation from interpretation also extends to how H₂ itself is measured. Hydrogen-rich water, for example, is sometimes characterized by its oxidation-reduction potential (ORP), with increasingly negative readings interpreted as evidence of higher dissolved hydrogen concentrations or stronger antioxidant properties. Yet a 2022 computational analysis demonstrated that ORP is strongly influenced by pH, temperature, and measurement limitations, meaning that water with a more negative ORP can contain less dissolved H₂ than another sample. This illustrates why a measurement should not be confused with the biological property it is assumed to represent. Establishing the concentration of molecular hydrogen requires an appropriate measurement of H₂ itself, while determining its biological effects requires a separate level of experimental evidence.
That distinction becomes increasingly important when moving from cellular experiments to human research. In a randomized, double-blind, placebo-controlled trial involving 68 adults with untreated hypercholesterolemia, ten weeks of hydrogen-rich water improved several experimentally measured functions of high-density lipoprotein (HDL), including its ability to promote cholesterol removal from cells through the ABCA1 transporter. The researchers also observed greater protection against LDL oxidation and inflammatory responses, even though circulating HDL cholesterol concentrations did not significantly change. The result illustrates why conventional clinical measurements do not always capture changes in underlying biological function. HDL cholesterol concentration describes how much cholesterol is carried within HDL particles, whereas cholesterol-efflux capacity describes one aspect of what those particles can do. Changes in the latter may be biologically informative even when the former remains unchanged, although improved HDL function in a laboratory assay does not by itself demonstrate a reduction in cardiovascular events.
Other human studies have examined physiological function more directly. In a randomized trial involving 34 healthy volunteers, consumption of hydrogen-rich water was associated with a significantly more favorable change in brachial-artery flow-mediated dilation relative to placebo, indicating an effect on how the artery responded to increased blood flow. A subsequent randomized trial involving 68 healthy volunteers assessed peripheral vascular responsiveness using reactive hyperemia measurements in the fingers. After 24 hours and again after two weeks of hydrogen-rich water consumption, the hydrogen group showed improvements in the logarithmic reactive hyperemia index, with significantly greater changes than the placebo group. These studies measured changes in vascular function rather than relying exclusively on circulating markers of oxidative stress or inflammation. They provide human evidence of physiological activity, while leaving open whether the observed changes persist with longer treatment or translate into fewer cardiovascular events.
Exercise research offers another opportunity to examine the difference between a biological response and its practical consequences. In a randomized, double-blind crossover study involving twelve elite finswimmers, hydrogen-rich water was associated with lower creatine kinase activity, less perceived muscle soreness, and slightly greater countermovement-jump height twelve hours after two strenuous training sessions performed on the same day. Unlike a study reporting only changes in oxidative-stress markers, this investigation included both biochemical measurements and indicators of physical recovery. However, the small sample and short observation period limit conclusions about longer-term training adaptation or athletic performance. The distinction is not between a biological effect and a clinical effect as entirely separate categories, but between different outcomes that become progressively more relevant to what an intervention might accomplish in practice.
These examples also demonstrate why a study that finds no change in one outcome does not necessarily contradict another study that identifies a different effect. In the HDL trial, cholesterol concentration and cholesterol-efflux capacity did not respond in the same way; in the vascular trials, researchers examined how blood vessels responded to changes in flow; and in the exercise study, muscle soreness, biochemical markers, and functional recovery were measured together. Each outcome addresses a different aspect of physiology. Their interpretation depends on understanding what was measured, how the measurement relates to biological function, and whether the observed difference is large enough to matter beyond the experimental setting.
At the same time, not every detectable physiological change translates into clinical improvement. In 2011, researchers examined hydrogen-enriched water in patients with mitochondrial and inflammatory myopathies using an initial open-label investigation followed by a randomized, double-blind, placebo-controlled crossover trial. The controlled trial found a significant change in serum lactate among patients with mitochondrial myopathy, but neither investigation demonstrated objective improvement in clinical symptoms. The biochemical result was relevant to mitochondrial metabolism, but it did not establish that the patients' underlying disease or physical function had meaningfully improved. This does not make the observed metabolic response irrelevant; it defines what the study demonstrated and what additional evidence would be required to establish clinical benefit.
A more recent example illustrates why even accumulating positive findings require attention to the magnitude of their effects. In 2026, a systematic review and meta-analysis combined 13 randomized trials involving 757 participants to evaluate the effects of hydrogen-rich water on circulating lipids in adults with overweight or obesity and associated metabolic disorders. Across the trials, hydrogen-rich water reduced total cholesterol by an average of 6.71 mg/dL and LDL cholesterol by 3.21 mg/dL, while triglycerides did not change significantly. The authors characterized the cholesterol reductions as statistically detectable but clinically modest and concluded that the findings did not justify routine use of hydrogen-rich water as a lipid-lowering treatment. These results are not incompatible with the earlier HDL-function findings, because the studies examined different aspects of lipoprotein biology. Rather, they reinforce the need to distinguish evidence of biological activity from the magnitude of benefit established for a particular clinical outcome.
Interpreting the broader H₂ literature also requires attention to differences among the interventions themselves. Human studies have administered H₂ through hydrogen-rich water, inhaled gas mixtures, and other formulations, with substantial variation in concentration, total exposure, treatment duration, and participant characteristics. These differences can complicate comparisons even when studies investigate similar biological processes. A concentration reported in parts per million (PPM) does not, by itself, establish the total amount of H₂ consumed, and findings obtained using one route of administration cannot automatically be transferred to another. Likewise, an effect observed in healthy volunteers or trained athletes may not have the same magnitude or relevance in patients with established disease. Differences in experimental conditions are therefore not minor details surrounding the findings; they are part of what determines how those findings should be interpreted.
Scientific uncertainty becomes misleading when it is treated as having only one meaning. Sometimes uncertainty reflects conflicting experimental results, insufficient statistical power, or the absence of adequately controlled human studies. In other cases, investigators may have demonstrated a reproducible biological effect while its precise mechanism or long-term clinical importance remains unresolved. Molecular hydrogen research contains examples of both, ranging from mechanistic investigations of mitochondrial signaling to randomized trials measuring vascular responsiveness, lipoprotein function, and other physiological outcomes. The presence of unanswered questions does not erase established experimental observations, but neither does the existence of those observations settle questions about therapeutic effectiveness.
The next stage of H₂ research will depend on connecting these levels of evidence more directly. Mechanistic studies can help identify the pathways and conditions under which H₂ produces biological effects, while larger, rigorously controlled peer-reviewed studies in people can determine whether those effects produce consistent improvements in symptoms, physical function, disease progression, or other clinically meaningful outcomes. Such studies will also need to establish how dose, delivery method, duration, and participant characteristics influence the response. These requirements are not unique to molecular hydrogen, but they are especially relevant to an intervention whose experimental effects have been investigated across numerous biological systems without an equally established range of clinical applications.
Ultimately, the scientific investigation of H₂ illustrates why understanding emerging research requires more than accepting or rejecting individual claims. A molecule once considered largely inert has demonstrated biological activity, while successive experiments have revealed mechanisms more complicated than the original antioxidant explanation suggested. Human studies have extended that investigation into measurable physiological functions, although the clinical significance of many findings remains uncertain. The important distinction is between what has been observed, what those observations may mean, and what has actually been established. Recognizing those differences allows scientific evidence to be taken seriously without demanding premature certainty or assigning it conclusions that have not yet been demonstrated.
References
· Dhillon, G., Buddhavarapu, V., Grewal, H., Sharma, P., Verma, R. K., Munjal, R., Devadoss, R., & Kashyap, R. (2024). Hydrogen Water: Extra Healthy or a Hoax?-A Systematic Review. International journal of molecular sciences, 25(2), 973. https://doi.org/10.3390/ijms25020973
· Fleming, T. R., & DeMets, D. L. (1996). Surrogate end points in clinical trials: are we being misled?. Annals of internal medicine, 125(7), 605–613. https://doi.org/10.7326/0003-4819-125-7-199610010-00011
· Ishibashi, T., Kawamoto, K., Matsuno, K., Ishihara, G., Baba, T., & Komori, N. (2020). Peripheral endothelial function can be improved by daily consumption of water containing over 7 ppm of dissolved hydrogen: A randomized controlled trial. PloS one, 15(5), e0233484. https://doi.org/10.1371/journal.pone.0233484
· Ito, M., Ibi, T., Sahashi, K., Ichihara, M., Ito, M., & Ohno, K. (2011). Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies. Medical gas research, 1(1), 24. https://doi.org/10.1186/2045-9912-1-24
· Iuchi, K., Imoto, A., Kamimura, N., Nishimaki, K., Ichimiya, H., Yokota, T., & Ohta, S. (2016). Molecular hydrogen regulates gene expression by modifying the free radical chain reaction-dependent generation of oxidized phospholipid mediators. Scientific reports, 6, 18971. https://doi.org/10.1038/srep18971
· LeBaron, T.W. & Sharpe, R. (2022). ORP should not be used to estimate or compare concentrations of aqueous H2: An in silico analysis and narrative synopsis. Frontiers in Food Science and Technology, 2. https://doi.org/10.3389/frfst.2022.1007001
· Negishi, S., Ito, M., Hasegawa, T., Otake, H., Ohkawara, B., Masuda, A., Mino, H., LeBaron, T. W., & Ohno, K. (2025). The Rieske iron-sulfur protein is a primary target of molecular hydrogen. Redox biology, 88, 103952. https://doi.org/10.1016/j.redox.2025.103952
· Ohsawa, I., Ishikawa, M., Takahashi, K., Watanabe, M., Nishimaki, K., Yamagata, K., Katsura, K., Katayama, Y., Asoh, S., & Ohta, S. (2007). Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature medicine, 13(6), 688–694. https://doi.org/10.1038/nm1577
· Ohta S. (2015). Molecular hydrogen as a novel antioxidant: overview of the advantages of hydrogen for medical applications. Methods in enzymology, 555, 289–317. https://doi.org/10.1016/bs.mie.2014.11.038
· Ostojic S. M. (2026). Revisiting molecular hydrogen signaling in mitochondria: Is the Rieske protein the entry point or a downstream sentinel?. Redox biology, 89, 104003. https://doi.org/10.1016/j.redox.2026.104003
· Pelikan, J. M., Link, T., Straßmayr, C., Waldherr, K., Alfers, T., Bøggild, H., Griebler, R., Lopatina, M., Mikšová, D., Nielsen, M. G., Peer, S., Vrdelja, M., & HLS19 Consortium of the WHO Action Network M-POHL (2022). Measuring Comprehensive, General Health Literacy in the General Adult Population: The Development and Validation of the HLS19-Q12 Instrument in Seventeen Countries. International journal of environmental research and public health, 19(21), 14129. https://doi.org/10.3390/ijerph192114129
· Penders, J., Kissner, R., & Koppenol, W. H. (2014). ONOOH does not react with H2: Potential beneficial effects of H2 as an antioxidant by selective reaction with hydroxyl radicals and peroxynitrite. Free radical biology & medicine, 75, 191–194. https://doi.org/10.1016/j.freeradbiomed.2014.07.025
· Sakai, T., Sato, B., Hara, K., Hara, Y., Naritomi, Y., Koyanagi, S., Hara, H., Nagao, T., & Ishibashi, T. (2014). Consumption of water containing over 3.5 mg of dissolved hydrogen could improve vascular endothelial function. Vascular health and risk management, 10, 591–597. https://doi.org/10.2147/VHRM.S68844
· Sies, H., & Jones, D. P. (2020). Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nature reviews. Molecular cell biology, 21(7), 363–383. https://doi.org/10.1038/s41580-020-0230-3
· Sládečková, B., Botek, M., Krejčí, J., Valenta, M., McKune, A., Neuls, F., & Klimešová, I. (2024). Hydrogen-rich water supplementation promotes muscle recovery after two strenuous training sessions performed on the same day in elite fin swimmers: randomized, double-blind, placebo-controlled, crossover trial. Frontiers in physiology, 15, 1321160. https://doi.org/10.3389/fphys.2024.1321160
· Song, G., Lin, Q., Zhao, H., Liu, M., Ye, F., Sun, Y., Yu, Y., Guo, S., Jiao, P., Wu, Y., Ding, G., Xiao, Q., & Qin, S. (2015). Hydrogen Activates ATP-Binding Cassette Transporter A1-Dependent Efflux Ex Vivo and Improves High-Density Lipoprotein Function in Patients With Hypercholesterolemia: A Double-Blinded, Randomized, and Placebo-Controlled Trial. The Journal of clinical endocrinology and metabolism, 100(7), 2724–2733. https://doi.org/10.1210/jc.2015-1321
· Sørensen, K., Van den Broucke, S., Fullam, J., Doyle, G., Pelikan, J., Slonska, Z., Brand, H., & (HLS-EU) Consortium Health Literacy Project European (2012). Health literacy and public health: a systematic review and integration of definitions and models. BMC public health, 12, 80. https://doi.org/10.1186/1471-2458-12-80
· Ye, H., Fang, J., Safargar, M., Fareed, H., Prabahar, K., & Jin, P. (2026). The effect of hydrogen-rich water interventions on lipid profiles in adults with overweight or obesity and associated metabolic disorders: a systematic review and meta-analysis of randomized controlled trials. Diabetology & metabolic syndrome, 18(1), 114. https://doi.org/10.1186/s13098-026-02124-0